PRO1184 for Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Endometrial Cancer|Non-small Cell Lung Cancer|Mesothelioma|Triple Negative Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor-positive Breast Cancer
Interventions: DRUG: PRO1184
Sponsor: ProfoundBio US Co.